What is it?
Coconut oil is a member of the family of tropical oils, which also include palm, palm
kernel, cocoa, and shea nut oils. These oils have been used for centuries in the traditional
diets of people living in tropical regions such as the Polynesian islands. Because these
populations experience less of the diseases, such as heart disease, that are common in Western
countries, some people believe that tropical oils such as coconut oil, especially in their
natural state, can be part of a healthful
diet.1 2 Currently, these oils are used in Western countries in
small amounts, primarily in the production of processed foods.
Tropical oils are high in saturated fat,
which has been associated with increased risk of
high blood cholesterol, atherosclerosis, and
heart disease.3 4 5 However, saturated fat is not a single
substance but rather a family of molecules having varying lengths, and coconut oil has more of
the shorter-length type of saturated fat molecules (known as lauric acid and myristic acid)
compared with most animal fats.6 This has led to speculation that coconut oil might
have different effects on cholesterol levels and heart disease risk compared with other
sources of saturated fats. Most controlled human studies, however, find significant
cholesterol-raising effects of diets high in either myristic acid,7 8
9 lauric acid,10 11 or a combination of these two fatty
acids,12 although this increase is usually a combination of both higher low-density
lipoprotein (LDL; “bad”) and high-density lipoprotein (HDL; “good”)
cholesterol.
Whether consuming coconut oil will result in unhealthy changes to blood cholesterol levels
is controversial. In a double-blind study of young men with normal cholesterol levels, coconut
oil was used to create a diet higher in both myristic and lauric acids, and this diet was
compared with a similar diet with longer-chain saturated fatty acids. The coconut oil diet
resulted in higher levels of both total and LDL cholesterol, whereas HDL levels were not
significantly different.13 Most other controlled studies of healthy young adults
have reported that coconut oil increases both LDL and HDL compared with either beef fat, palm
oil, or vegetable oils high in unsaturated fats.14 15 16
17 A controlled study of Polynesians found that a diet with coconut oil resulted in
lower LDL levels compared with butter, while HDL was not different between the two
diets.18 However, one trial found no difference in the effects on cholesterol
levels of a diet containing small amounts (4% of total calorie intake) of coconut oil compared
with similar diets containing other fat sources.19 More research is needed to
determine whether consuming coconut oil will affect the risk of atherosclerosis and heart
disease.
Animal studies suggest that coconut oil can affect energy and fat metabolism in a way that
could improve the results of a weight-loss diet.20 In a two-week double-blind trial investigating the effect of dietary fat on
fat metabolism, a diet containing shorter-chain saturated fatty acids from coconut oil and
butter was compared with one containing longer-chain saturated fatty acids from beef
fat.21 The coconut oil-butter diet led to changes in fat metabolism that suggested
that eating these fats might result in better control of body weight. However, no studies have
investigated whether consuming coconut oil actually affects body weight.
According to test tube studies, some of the fatty acids present in coconut oil have
antibacterial,22 23 24 antiviral,25 26
27 28 and immune
system-stimulating effects,29 suggesting that coconut oil might be helpful in
fighting infections. However, no research has investigated these possible effects in
humans.
Synthetic fats resembling those found in coconut oil have been found to have anticancer
effects in animals but whether these effects would be possible in humans consuming coconut oil
is unknown.30 31
References
1. Prior IA, Davidson F, Salmond CE, Czochanska Z. Cholesterol, coconuts,
and diet on Polynesian atolls: a natural experiment: the Pukapuka and Tokelau island studies.
Am J Clin Nutr 1981;34:1552–61.
2. Kaunitz H, Dayrit CS. Coconut oil consumption and coronary heart
disease. Philippine J Intern Med 1992;30:165–71 [review].
3. Hu FB, Stampfer MJ, Manson JE, et al. Dietary fat intake and the risk
of coronary heart disease in women. N Engl J Med 1997;337:1491–9.
4. Kromhout D, Menotti A, Bloemberg B, et al. Dietary saturated and trans
fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven
Countries Study. Prev Med 1995;24:308–15.
5. Tell GS, Evans GW, Folsom AR, et al. Dietary fat intake and carotid
artery wall thickness: the Atherosclerosis Risk in Communities (ARIC) study. Am J
Epidemiol 1994;139:979–89.
6. Grundy SM, Denke MA. Dietary influences on serum lipids and
lipoproteins. J Lipid Res 1990;31:1149–72 [review].
7. Zock PL, de Vries JHM, Katan MB. Impact of myristic acid versus
palmitic acid on serum lipid and lipoprotein levels in healthy women and men. Arterioscler
Thromb 1994;14:567–75.
8. Temme EH, Mensink RP, Hornstra G. Effects of medium chain fatty acids
(MCFA), myristic acid, and oleic acid on serum lipoproteins in healthy subjects. J Lipid
Res 1997;38:1746–54.
9. Tholstrup T, Marckmann P, Jespersen J, et al. Effect on blood lipids,
coagulation, and fibrinolysis of a fat high in myristic acid and a fat high in palmitic acid.
Am J Clin Nutr 1994;60:919–25.
10. Denke MA, Grundy SM. Comparison of effects of lauric acid and
palmitic acid on plasma lipids and lipoproteins. Am J Clin Nutr
1992;56:895–8.
11. Temme EH, Mensink RP, Hornstra G. Comparison of the effects of diets
enriched in lauric, palmitic, or oleic acids on serum lipids and lipoproteins in healthy women
and men. Am J Clin Nutr 1996;63:897–903.
12. Sundram K, Hayes KC, Siru OH. Dietary palmitic acid results in lower
serum cholesterol than does a lauric-myristic acid combination in normolipemic humans. Am
J Clin Nutr 1994;59:841–6.
13. Sundram K, Hayes KC, Siru OH. Dietary palmitic acid results in lower
serum cholesterol than does a lauric-myristic acid combination in normolipemic humans. Am
J Clin Nutr 1994;59:841–6.
14. Ng TK, Hassan K, Lim JB, et al. Nonhypercholesterolemic effects of a
palm-oil diet in Malaysian volunteers. Am J Clin Nutr 1991;53:1015S–1020S.
15. Mendis S, Kumarasunderam R. The effect of daily consumption of
coconut fat and soya-bean fat on plasma lipids and lipoproteins of young normolipidaemic men.
Br J Nutr 1990;63:547–52.
16. Reiser R, Probstfield JL, Silvers A, Plasma lipid and lipoprotein
response of humans to beef fat, coconut oil and safflower oil. Am J Clin Nutr
1985;42:190–7.
17. Muller H, Lindman AS, Brantsaeter AL, Pedersen JI. The serum LDL/HDL
cholesterol ratio is influenced more favorably by exchanging saturated with unsaturated fat
than by reducing saturated fat in the diet of women. J Nutr 2003;133:78–83.
18. Cox C, Sutherland W, Mann J, et al. Effects of dietary coconut oil,
butter and safflower oil on plasma lipids, lipoproteins and lathosterol levels. Eur J Clin
Nutr 1998;52:650–4.
19. Schwab US, Niskanen LK, Maliranta HM, et al. Lauric and palmitic
acid-enriched diets have minimal impact on serum lipid and lipoprotein concentrations and
glucose metabolism in healthy young women. J Nutr 1995;125:466–73.
20. Portillo MP, Serra F, Simon E, et al. Energy restriction with
high-fat diet enriched with coconut oil gives higher UCP1 and lower white fat in rats. Int
J Obes Relat Metab Disord 1998;22:974–9.
21. Papamandjaris AA, White MD, Raeini-Sarjaz M, Jones PJ. Endogenous fat
oxidation during medium chain versus long chain triglyceride feeding in healthy women. Int
J Obes Relat Metab Disord 2000;24:1158–66.
22. Sun CQ, O'Connor CJ, Roberton AM. Antibacterial actions of fatty
acids and monoglycerides against Helicobacter pylori. FEMS Immunol Med Microbiol
2003;36:9–17.
23. Ruzin A, Novick RP. Equivalence of lauric acid and glycerol
monolaurate as inhibitors of signal transduction in Staphylococcus aureus. J
Bacteriol 2000;182:2668–71.
24. Bergsson G, Arnfinnsson J, Karlsson SM, et al. In vitro inactivation
of Chlamydia trachomatis by fatty acids and monoglycerides. Antimicrob Agents
Chemother 1998;42:2290–4.
25. Bartolotta S, Garcia CC, Candurra NA, Damonte EB. Effect of fatty
acids on arenavirus replication: inhibition of virus production by lauric acid. Arch
Virol 2001;146:777–90.
26. Kristmundsdottir T, Arnadottir SG, Bergsson G, Thormar H. Development
and evaluation of microbicidal hydrogels containing monoglyceride as the active ingredient.
J Pharm Sci 1999;88:1011–5.
27. Hornung B, Amtmann E, Sauer G. Lauric acid inhibits the maturation of
vesicular stomatitis virus. J Gen Virol 1994;75:353–61.
28. Ismail-Cassim N, Chezzi C, Newman JF. Inhibition of the uncoating of
bovine enterovirus by short chain fatty acids. J Gen Virol 1990;71:2283–9.
29. Witcher KJ, Novick RP, Schlievert PM. Modulation of immune cell
proliferation by glycerol monolaurate. Clin Diagn Lab Immunol 1996;3:10–3.
30. Ngwenya BZ, Fiavey NP, Mogashoa MM. Anti-neoplastic action of
peritoneal macrophages following oral administration of ether analogues of lysophospholipids.
Eur J Cancer 1992;28A:1637–42.
31. Ngwenya BZ, Fiavey NP, Mogashoa MM. Activation of peritoneal
macrophages by orally administered ether analogues of lysophospholipids. Proc Soc Exp Biol
Med 1991;197:91–7.
32. Rosado A, Fernandez-Rivas M, Gonzalez-Mancebo E, et al. Anaphylaxis
to coconut. Allergy 2002;57:182–3.
33. Teuber SS, Peterson WR. Systemic allergic reaction to coconut (Cocos
nucifera) in 2 subjects with hypersensitivity to tree nut and demonstration of
cross-reactivity to legumin-like seed storage proteins: new coconut and walnut food allergens.
J Allergy Clin Immunol 1999;103:1180–5.
34. Couturier P, Basset-Stheme D, Navette N, Sainte-Laudy J. A case of
coconut oil allergy in an infant: responsibility of "maternalized" infant formulas. Allerg
Immunol (Paris) 1994;26:386–7 [in French].